332
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Relationships among Type-D personality, symptoms and quality of life in patients with ovarian cancer receiving chemotherapy

, &
Pages 289-296 | Received 13 Apr 2017, Accepted 21 Aug 2017, Published online: 11 Sep 2017

References

  • Sant M, Chirlaque L, Agresti R, et al. Survival of women with cancers of breast and genital organs in Europe 1999–2007: results of the EUROCARE-5 study. Eur J Cancer. 2016;51:2191–2205.
  • Bhugwandass CS, Pijnenborg JM, Pijlman B, et al. Effect of chemotherapy on health-related quality of life among early-stage ovarian cancer survivors: a study from the population-based PROFILES registry. Curr Oncol. 2016;23:e556–e562.
  • Vitale SG, Marilli I, Lodato M, et al. The role of cytoreductive surgery in advanced-stage ovarian cancer: a systematic review. Updates Surg. 2013;65:265–270.
  • Bellia A, Vitale SG, Laganà AS, et al. Feasibility and surgical outcomes of conventional and robot-assisted laparoscopy for early-stage ovarian cancer: a retrospective, multicenter analysis. Arch Gynecol Obstet. 2016;294:615–622.
  • Laganà AS, Sofo V, Vitale SG, et al. Epithelial ovarian cancer inherent resistance: may the pleiotropic resistant cells play a key role? Gynecol Oncol Rep. 2016;18:57–58.
  • Laganà AS, Colonese F, Colonese E, et al. Cytogenetic analysis of epithelial ovarian cancer’s stem cells: an overview on new diagnostic and therapeutic perspectives. Eur J Gynaecol Oncol. 2015;36:495–505.
  • Bell J, Brady MF, Young CR, et al. Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2006;102:432–439.
  • Hwang KH, Cho OH, Yoo YS. Symptom clusters of ovarian cancer patients undergoing chemotherapy, and their emotional status and quality of life. Eur J Oncol Nurs. 2016;21:215–222.
  • Vitale SG, La Rosa VL, Rapisarda AM, et al. The importance of fertility preservation counseling in patients with gynecologic cancer. J Reprod Infertil. 2017;18:261–263.
  • Zhou Y, Irwin ML, Ferrucci LM, et al. Health-related quality of life in ovarian cancer survivors: results from the American Cancer Society's Study of Cancer Survivors - I. Gynecol Oncol. 2016;141:543–549.
  • Denollet J. DS14: standard assessment of negative affectivity, social inhibition, and Type D personality. Psychosom Med. 2005;67:89–97.
  • Pedersen SS, Herrmann-Lingen C, de Jonge P, et al. Type D personality is a predictor of poor emotional quality of life in primary care heart failure patients independent of depressive symptoms and New York Heart Association functional class. J Behav Med. 2010;33:72–80.
  • Schiffer AA, Pedersen SS, Widdershoven JW, et al. Type D personality and depressive symptoms are independent predictors of impaired health status in chronic heart failure. Eur J Heart Fail. 2008;10:922–930.
  • Husson O, Denollet J, Ezendam NPM, et al. Personality, health behaviors, and quality of life among colorectal cancer survivors: results from the PROFILES registry. J Psychosoc Oncol. 2017;35:61–76.
  • Shun SC, Yeh KH, Liang JT, et al. Unmet supportive care needs of patients with colorectal cancer: significant differences by type D personality. Oncol Nurs Forum. 2014;41:E3–E11.
  • Zhang JK, Fang LL, Zhang DW, et al. Type D personality is associated with delaying patients to medical assessment and poor quality of life among rectal cancer survivors. Int J Colorectal Dis. 2016;31:75–85.
  • Mols F, Thong MS, van de Poll-Franse LV, et al. Type D (distressed) personality is associated with poor quality of life and mental health among 3080 cancer survivors. J Affect Disord. 2012;136:26–34.
  • Watts S, Prescott P, Mason J, et al. Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2015;5:e007618.
  • Pinar G, Okdem S, Buyukgonenc L, et al. The relationship between social support and the level of anxiety, depression, and quality of life of Turkish women with gynecologic cancer. Cancer Nurs. 2012;35:229–235.
  • Vitale SG, La Rosa VL, Rapisarda AM, et al. Comment on: anxiety and depression in patients with advanced ovarian cancer: a prospective study. J Psychosom Obstet Gynaecol. 2017;38:83–84.
  • Vitale SG, La Rosa VL, Rapisarda AM, et al. Comment on: the consequences of gynaecological cancer in patients and their partners from the sexual and psychological perspective. PM. 2016;15:186–187.
  • Bukovic D, Silovski H, Silovski T, et al. Sexual functioning and body image of patients treated for ovarian cancer. Sex Disabil. 2008;26:63–73.
  • Jayde V, Boughton M, Blomfield P. The experience of chemotherapy-induced alopecia for Australian women with ovarian cancer. Eur J Cancer Care (Engl). 2013;22:503–512.
  • Nezlek JB. Body image and day-to-day social interaction. J Pers. 1999;67:793–817.
  • Roland KB, Rodriguez JL, Patterson JR, et al. A literature review of the social and psychological needs of ovarian cancer survivors. Psychooncology. 2013;22:2408–2418.
  • Lim EH, Lee MS, Ko YH, et al. Assessment of the Type D personality construct in the Korean population: a validation study of the Korean DS14. J Korean Med Sci. 2011;26:116–123.
  • Chang VT, Hwang SS, Feuerman M, et al. The memorial symptom assessment scale short form (MSAS-SF). Cancer. 2000;89:1162–1171.
  • Lam WW, Law CC, Fu YT, et al. New insights in symptom assessment: the Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS). J Pain Symptom Manage. 2008;36:584–595.
  • Webber K, Davies AN. Validity of the memorial symptom assessment scale-short form psychological subscales in advanced cancer patients. J Pain Symptom Manage. 2011;42:761–767.
  • Yuceege M, Sanisoglu B, Firat H, et al. The clinical utility of Memorial Symptom Assessment-Short Form and Condensed Memorial Symptom Assessment Scale in Turkish lung cancer patients. Clin Respir J. 2015;9:221–227.
  • Cella D. FACIT manual: manual of the Functional Assessment of Chronic Illness Therapy (FACIT) measurement system. Evanston (IL): Center on Outcomes, Research and Education; 1997.
  • Prat J, Oncology FCoG. FIGO’s staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication. J Gynecol Oncol. 2015;26:87–89.
  • Webster K, Odom L, Peterman A, et al. The FACIT measurement system: validation of version 4 the core questionnaire. Qual Life Res. 1999;8:604.
  • Sorensen JB, Klee M, Palshof T, et al. Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer. 1993;67:773–775.
  • Chase DM, Wenzel L. Health-related quality of life in ovarian cancer patients and its impact on clinical management. Expert Rev Pharmacoecon Outcomes Res. 2011;11:421–431.
  • Mols F, Denollet J. Type D personality among noncardiovascular patient populations: a systematic review. Gen Hosp Psychiatry. 2010;32:66–72.
  • Mols F, Holterhues C, Nijsten T, et al. Personality is associated with health status and impact of cancer among melanoma survivors. Eur J Cancer. 2010;46:573–580.
  • Kim SR, Kim HK, Kang JH, et al. Does type D personality affect symptom control and quality of life in asthma patients? J Clin Nurs. 2015;24:739–748.
  • Son YJ, You MA, Song EK. Influence of Type D personality on health-related quality of life among Korean patients with end-stage renal disease. Int J Nurs Pract. 2012;18:260–267.
  • Kim SR, Kim JY, Kim HK, et al. Association among type D personality, non-motor symptoms, and quality of life in Parkinson’s disease: a cross-sectional study. Geriatr Nurs. 2017 [cited 2017 Mar 18]. DOI:10.1016/j.gerinurse.2017.02.006
  • Thomas G, de Jong FI, Kooijman PG, et al. Utility of the Type D Scale 16 and Voice Handicap Index to assist voice care in student teachers and teachers. Folia Phoniatr Logop. 2006;58:250–263.
  • Bae SH, Park JH, Oh E. A comparison of the health status and health promoting behaviors between type D personality and non-type D personality in middle aged women. Korean J Women Health Nurs. 2011;17:337–345.
  • Denollet J. Type D personality a potential risk factor refined. J Psychosom Res. 2000;49:255–266.
  • Herrmann-Lingen C, Beutel ME, Bosbach A, et al. A stepwise psychotherapy intervention for reducing risk in coronary artery disease: results of an observer-blinded, multicenter, randomized trial in depressed patients with coronary artery disease. Psychosom Med. 2016;78:704–715.
  • Cao X, Wong EM, Chow Choi K, et al. Interventions for cardiovascular patients with Type D personality: a systematic review. Worldviews Evid Based Nurs. 2016;13:314–323.
  • Laganà AS, La Rosa VL, Rapisarda AMC, et al. Psychological impact of fertility preservation techniques in women with gynaecological cancer. eCancer. 2017;11:ed62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.